indaptus_logo.png
Indaptus Therapeutics Previews Positive Mechanism of Action Data to be Presented at the American Association for Cancer Research Annual Meeting
March 25, 2024 08:30 ET | Indaptus Therapeutics
Data demonstrates that Company’s Decoy platform successfully induces or activates multiple immune cell types involved in anti-tumor responses New data shows activity in M1 macrophages, natural...
SAFE PRINT 360 - DEFENDER AGAINST BACTERIA
March 10, 2021 15:07 ET | Flottman Company
Cincinnati, Ohio - Northern Kentucky, March 10, 2021 (GLOBE NEWSWIRE) -- Introducing Safe Print 360, Flottman Company’s new antimicrobial substrate coating, formulated to inhibit 99% of bacterial...